CURNA is a therapeutics company which is utilizing novel non-coding RNA technology exclusively licensed from Scripps Florida to develop therapies for many important diseases for which no cure is currently available. The company was founded in 2008 by Scripps Florida Professor Claes Wahlestedt and South Florida entrepreneur Joseph Collard as a Scripps Florida spinoff.

At CURNA our mission is to make sense. Our research is focused on the therapeutic use of the sense strand of DNA and our approach to drug development makes sense both scientifically and biologically as we employ the body’s own cellular apparatus to produce the “drugs” required to combat the targeted disease state.

News:

Cures for disease, area economy

Scripps Florida spinoff builds on advanced non-coding RNA technology